Search Within

Mark Weiss

  1. "Molecular Pharmacology and Chemistry Program Faculty"
Formats
  1. Meeting Abstract (26)
  2. Journal Article (11)
  3. Book Section (4)
Groups
  1. Adult Leukemia (41)
  2. Center for Hematologic Malignancies (41)
  3. Department of Medicine (41)
  4. GSK Faculty (41)
  5. Hematologic Malignancies Research (41)
  6. Hematologic Malignancies, Division of (41)

More Groups

People
  1. David Scheinberg (38)
  2. Peter Maslak (34)
  3. Joseph Jurcic (18)
  4. Nicole Lamanna (11)
  5. Ellin Berman (10)
  6. Denise Horgan (9)

More People

Years
  1. 2014 (1)
  2. 2010 (1)
  3. 2009 (2)
  4. 2008 (2)
  5. 2006 (1)
  6. 2005 (4)

More Years

Publications
  1. Blood (23)
  2. Journal of Clinical Oncology (7)
  3. Leukemia (4)
  4. Cancer: Principles and Practice of Oncology. 5th ed (2)
  5. Cancer (1)
  6. Cancer: Principles and Practice of Oncology. 6th ed (1)

More Publications

Publishers
  1. American Society of Hematology (23)
  2. American Society of Clinical Oncology (7)
  3. Nature Publishing Group (5)
  4. Lippincott Williams & Wilkins (2)
  5. Lippincott-Raven (2)
  6. Elsevier Inc. (1)

More Publishers

Results (41)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The Warburg effect confers adverse outcome in chronic lymphocytic leukemia
    Meeting Abstract

    Gardner, J. R.; Devlin, S. M.; Knapp, K.; Bauli, F.; Patel, M.; Lamanna, N.; Frattini, M. G.; Brentjens, R.; Maslak, P.; Jurcic, J. G.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2014)

    Fulltext@MSK | Save
  • Vaccination with synthetic analog peptides derived from WT1 oncoprotein induces T-cell responses in patients with complete remission from acute myeloid leukemia
    Journal Article

    Maslak, P. G.; Dao, T.; Krug, L. M.; Chanel, S.; Korontsvit, T.; Zakhaleva, V.; Zhang, R.; Wolchok, J. D.; Yuan, J.; Pinilla-Ibarz, J.; more...
    Blood (2010)

    Fulltext@MSK | Save
  • Enhanced in vivo activation of adoptively transferred genetically targeted T cells following cyclophosphamide chemotherapy: Initial results from a phase I clinical trial treating CLL patients with autologous CD19-targeted T cells
    Meeting Abstract

    Brentjens, R. J.; Hollyman, D.; Park, J.; Santos, E.; Yeh, R.; Stefanski, J.; Taylor, C.; Weiss, M. A.; Filippa, D.; Riviere, I.; more...
    Blood (2009)

    Fulltext@MSK | Save
  • Sequential therapy with fludarabine, high-dose cyclophosphamide, and rituximab in previously untreated patients with chronic lymphocytic leukemia produces high-quality responses: Molecular remissions predict for durable complete responses
    Journal Article

    Lamanna, N.; Jurcic, J. G.; Noy, A.; Maslak, P.; Gencarelli, A. N.; Panageas, K. S.; Heaney, M. L.; Brentjens, R. J.; Golde, D. W.; Scheinberg, D. A.; more...
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • A phase I trial for the treatment of purine analog-refractory chronic lymphocytic leukemia using autologous T cells genetically targeted to the B cell specific antigen CD19
    Meeting Abstract

    Brentjens, R. J.; Hollyman, D.; Weiss, M.; Stefanski, J.; Przybylowski, M.; Bartido, S.; Borquez-Ojeda, O.; Taylor, C.; Heaney, M.; Riviere, I.; more...
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Sequential cytarabine and alpha-particle immunotherapy with bismuth-213 ((213)Bi)-labeled-HuM195 (lintuzumab) for acute myeloid leukemia (AML)
    Meeting Abstract

    Rosenblat, T.; McDevitt, M. R.; Mulford, D. A.; Pandit-Taskar, N.; Weiss, M. A.; Heaney, M. L.; Chanel, S.; Morgenstern, A.; Larson, S. M.; Scheinberg, D. A.; more...
    Blood (2008)

    Fulltext@MSK | Save
  • Pentostatin, cyclophosphamide, and rituximab is an active, well-tolerated regimen for patients with previously treated chronic lymphocytic leukemia
    Journal Article

    Lamanna, N.; Kalaycio, M.; Maslak, P.; Jurcic, J. G.; Heaney, M.; Brentjens, R.; Zelenetz, A. D.; Horgan, D.; Gencarelli, A.; Panageas, K. S.; more...
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • Management of acute leukemias
    Book Section

    Scheinberg, D. A.; Maslak, P. G.; Weiss, M. A.
    In DeVita, V. T.; Hellman, S.; Rosenberg, S. A. (Eds.) Cancer: Principles and Practice of Oncology. 7th ed (2005)

    Fulltext@MSK | Save
  • A randomized trial of cytarabine with high-dose mitoxantrone compared to a standard vincristine/prednisone-based regimen as induction therapy for adult patients with ALL
    Meeting Abstract

    Weiss, M. A.; Heffner, L.; Lamanna, N.; Kalaycio, M.; Schiller, G.; Coutre, S.; Maslak, P.; Jurcic, J.; Panageas, K.; Scheinberg, D. A.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Pentostatin, cyclophosphamide, and rituximab (PCR) has comparable activity but appears to be better tolerated than fludarabine, cyclophosphamide, and rituximab (FCR) in patients with previously treated chronic lymphocytic leukemia
    Meeting Abstract

    Lamanna, N.; Kalaycio, M.; Maslak, P.; Heaney, M. L.; Brentjens, R.; Jurcic, J.; Biederman, E.; Gencarelli, A. N.; Panageas, K. S.; Scheinberg, D. A.; more...
    Blood (2005)

    Fulltext@MSK | Save